News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,087 Results
Type
Article (88413)
Company Profile (812)
Press Release (787832)
Multimedia
Podcasts (219)
Webinars (34)
Section
Business (233430)
Career Advice (4155)
Deals (39923)
Drug Delivery (168)
Drug Development (91556)
Employer Resources (207)
FDA (18486)
Job Trends (17457)
News (398354)
Policy (40006)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (3036)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (175)
Alliances (56985)
ALS (209)
Alzheimer's disease (1895)
Antibody-drug conjugate (ADC) (429)
Approvals (18727)
Artificial intelligence (755)
Autoimmune disease (256)
Automation (55)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (486)
Bladder cancer (187)
Brain cancer (75)
Breast cancer (736)
Cancer (5767)
Cardiovascular disease (512)
Career advice (3584)
Career pathing (47)
CAR-T (337)
CDC (72)
Celiac Disease (2)
Cell therapy (929)
Cervical cancer (45)
Clinical research (77968)
Collaboration (2137)
Company closure (7)
Compensation (1337)
Complete response letters (96)
COVID-19 (3018)
CRISPR (111)
C-suite (1086)
Cystic fibrosis (161)
Data (7357)
Decentralized trials (3)
Denatured (82)
Depression (179)
Dermatology (67)
Diabetes (598)
Diagnostics (7423)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (378)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (287)
Earnings (101357)
Editorial (72)
Employer branding (25)
Employer resources (174)
Events (136649)
Executive appointments (1121)
FDA (22120)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1768)
Gene editing (239)
Generative AI (84)
Gene therapy (758)
GLP-1 (1216)
Government (5516)
Grass and pollen (8)
Guidances (404)
Healthcare (21047)
HIV (82)
Huntington's disease (58)
IgA nephropathy (97)
Immunology and inflammation (330)
Immuno-oncology (96)
Indications (164)
Infectious disease (3374)
Inflammatory bowel disease (224)
Inflation Reduction Act (17)
Influenza (141)
Intellectual property (287)
Interviews (817)
IPO (17977)
IRA (61)
Job creations (5204)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (105)
Layoffs (669)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (30)
Lung cancer (767)
Lymphoma (421)
Machine learning (57)
Management (66)
Manufacturing (1046)
MASH (195)
Medical device (15167)
Medtech (15252)
Mergers & acquisitions (23136)
Metabolic disorders (1610)
mRNA (218)
Multiple sclerosis (186)
NASH (24)
Neurodegenerative disease (440)
Neuropsychiatric disorders (117)
Neuroscience (3448)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (785)
Opinion (359)
Ovarian cancer (202)
Pain (255)
Pancreatic cancer (274)
Parkinson's disease (371)
Partnered (39)
Patents (594)
Patient recruitment (640)
Peanut (65)
People (67475)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24083)
Phase 2 (33850)
Phase 3 (25476)
Pipeline (7555)
Policy (374)
Postmarket research (3555)
Preclinical (10800)
Press Release (72)
Prostate cancer (294)
Psychedelics (61)
Radiopharmaceuticals (336)
Rare diseases (1128)
Real estate (7448)
Recruiting (81)
Regulatory (29742)
Reports (74)
Research institute (2756)
Resumes & cover letters (653)
Rett syndrome (34)
RNA editing (23)
RSV (96)
Schizophrenia (180)
Series A (294)
Series B (219)
Service/supplier (30)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (186)
Sponsored (52)
Startups (4350)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (134)
Vaccines (1238)
Venture capital (111)
Weight loss (537)
Women's health (120)
Worklife (23)
Date
Today (115)
Last 7 days (598)
Last 30 days (2671)
Last 365 days (32898)
2026 (9417)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (372)
Arkansas (16)
Asia (51913)
Australia (9122)
California (12924)
Canada (3668)
China (1354)
Colorado (558)
Connecticut (566)
Delaware (392)
Europe (119541)
Florida (1933)
Georgia (424)
Hawaii (4)
Idaho (69)
Illinois (1103)
India (92)
Indiana (609)
Iowa (24)
Japan (517)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1594)
Massachusetts (9471)
Michigan (394)
Minnesota (735)
Mississippi (7)
Missouri (156)
Montana (37)
Nebraska (30)
Nevada (143)
New Hampshire (90)
New Jersey (3476)
New Mexico (33)
New York (3431)
North Carolina (1763)
North Dakota (10)
Northern California (6307)
Ohio (401)
Oklahoma (26)
Oregon (54)
Pennsylvania (2588)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (83)
South Dakota (2)
Southern California (5041)
Tennessee (206)
Texas (2082)
United States (46559)
Utah (389)
Vermont (1)
Virginia (329)
Washington D.C. (88)
Washington State (1068)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
There are 877,087 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
On steadier ground, pharma heads into Q1 earnings with deals top of mind
During the pharma earnings season, which begins on Tuesday, Novo Nordisk will report the first revenue numbers from an oral GLP-1 medicine, while other companies are expected to address the FDA, drug pricing and Trump’s new tariffs.
April 14, 2026
·
5 min read
·
Annalee Armstrong
Approvals
Travere’s Filspari overcomes Phase 3 fail to become first drug for rare kidney disease
The FDA has greenlit Travere Therapeutics’ Filspari as the only available treatment for focal segmental glomerulosclerosis despite the drug’s loss to Sanofi’s Avapro in a Phase 3 study.
April 14, 2026
·
2 min read
·
Tristan Manalac
IPO
Kailera eyes record $533M+ IPO to play in competitive obesity space with Chinese drugs
Kailera Therapeutics is advancing a pipeline of obesity drugs, led by the GLP-1/GIP dual agonist ribupatide, which the biotech is developing both as an injectable and as a pill.
April 14, 2026
·
2 min read
·
Tristan Manalac
Regulatory
FDA asks 2,200 drug developers to make trial results public, ramping up transparency push
Some 30% of clinical trials that are mandated to report their findings have not posted results to clinicaltrials.gov, the federal government’s public repository for studies, according to internal data from the FDA.
April 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development
April 14, 2026
·
4 min read
Press Releases
Mestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting
April 14, 2026
·
3 min read
Press Releases
BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
April 14, 2026
·
6 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Annual IND Report with FDA
April 14, 2026
·
4 min read
Press Releases
Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered
April 14, 2026
·
3 min read
Press Releases
Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma
April 14, 2026
·
5 min read
1 of 87,709
Next
